Tekla Capital Management’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-70,176
| Closed | -$10.6M | – | 179 |
|
|
2022
Q3 | $10.6M | Hold |
70,176
| – | – | 0.43% | 53 |
|
|
2022
Q2 | $10.2M | Hold |
70,176
| – | – | 0.4% | 60 |
|
|
2022
Q1 | $8.32M | Hold |
70,176
| – | – | 0.29% | 71 |
|
|
2021
Q4 | $9.67M | Sell |
70,176
-20,623
| -23% | -$2.84M | 0.31% | 71 |
|
|
2021
Q3 | $12.6M | Buy |
+90,799
| New | +$12.6M | 0.41% | 59 |
|
|
2020
Q4 | – | Sell |
-34,277
| Closed | -$2.23M | – | 216 |
|
|
2020
Q3 | $2.23M | Hold |
34,277
| – | – | 0.08% | 150 |
|
|
2020
Q2 | $2.51M | Sell |
34,277
-10,887
| -24% | -$796K | 0.1% | 150 |
|
|
2020
Q1 | $1.54M | Buy |
45,164
+16,039
| +55% | +$546K | 0.07% | 151 |
|
|
2019
Q4 | $1.59M | Hold |
29,125
| – | – | 0.06% | 159 |
|
|
2019
Q3 | $1.22M | Buy |
+29,125
| New | +$1.22M | 0.05% | 151 |
|
|
2018
Q2 | – | Sell |
-162,477
| Closed | -$4.19M | – | 198 |
|
|
2018
Q1 | $4.19M | Buy |
+162,477
| New | +$4.19M | 0.16% | 98 |
|